Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 1
2009 1
2011 7
2012 5
2013 7
2014 10
2015 11
2016 18
2017 15
2018 11
2019 13
2020 18
2021 23
2022 20
2023 25
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE.
Kinzler MN, Bankov K, Bein J, Döring C, Schulze F, Reis H, Mahmoudi S, Koch V, Grünewald LD, Stehle A, Walter D, Finkelmeier F, Zeuzem S, Wild PJ, Vogl TJ, Bernatz S. Kinzler MN, et al. Among authors: reis h. Curr Oncol. 2023 Mar 20;30(3):3516-3528. doi: 10.3390/curroncol30030267. Curr Oncol. 2023. PMID: 36975480 Free PMC article.
[Current diagnostic and treatment strategies for urachal cancer].
Módos O, Váradi M, Dér B, Keszthelyi A, Szűcs M, Reis H, Nyirády P, Szarvas T. Módos O, et al. Among authors: reis h. Orv Hetil. 2023 Apr 23;164(16):602-609. doi: 10.1556/650.2023.32754. Print 2023 Apr 23. Orv Hetil. 2023. PMID: 37087728 Review. Hungarian.
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
Paner GP, Kamat A, Netto GJ, Samaratunga H, Varma M, Bubendorf L, van der Kwast TH, Cheng L; Members of the ISUP Bladder Tumor Consensus Panel. Paner GP, et al. Am J Surg Pathol. 2024 Jan 1;48(1):e11-e23. doi: 10.1097/PAS.0000000000002077. Epub 2023 Jun 29. Am J Surg Pathol. 2024. PMID: 37382156
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Varadi M, Nagy N, Reis H, Hadaschik B, Niedworok C, Modos O, Szendroi A, Ablat J, Black PC, Keresztes D, Csizmarik A, Olah C, Gaisa NT, Kiss A, Timar J, Toth E, Csernak E, Gerstner A, Mittal V, Karkampouna S, Kruithof de Julio M, Gyorffy B, Bedics G, Rink M, Fisch M, Nyirady P, Szarvas T. Varadi M, et al. Among authors: reis h. Cancer Med. 2023 Apr;12(7):9041-9054. doi: 10.1002/cam4.5639. Epub 2023 Jan 20. Cancer Med. 2023. PMID: 36670542 Free PMC article.
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility.
Warrick JI, Al-Ahmadie H, Berman DM, Black PC, Flaig TW, Höglund M, Bubendorf L, van der Kwast TH, Cheng L; Members of the ISUP Bladder Tumor Consensus Panel. Warrick JI, et al. Am J Surg Pathol. 2024 Jan 1;48(1):e32-e42. doi: 10.1097/PAS.0000000000002053. Epub 2023 May 18. Am J Surg Pathol. 2024. PMID: 37199442 Review.
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading.
Tolkach Y, Ovtcharov V, Pryalukhin A, Eich ML, Gaisa NT, Braun M, Radzhabov A, Quaas A, Hammerer P, Dellmann A, Hulla W, Haffner MC, Reis H, Fahoum I, Samarska I, Borbat A, Pham H, Heidenreich A, Klein S, Netto G, Caie P, Buettner R. Tolkach Y, et al. Among authors: reis h. NPJ Precis Oncol. 2023 Aug 15;7(1):77. doi: 10.1038/s41698-023-00424-6. NPJ Precis Oncol. 2023. PMID: 37582946 Free PMC article.
164 results